Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ohnuma

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Combination of chemotherapy and immunotherapy in man--review]T Ohnuma
Nippon Ganka Gakkai Zasshi|January 1, 1983
[Visual evoked potentials elicited by sinusoidal gratings in optic nerve disorders]T Ohnuma
Nippon Ganka Gakkai Zasshi|December 10, 1982
[Checkerboard pattern reversal VEPs in optic nerve disorders]T Ohnuma
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1979
[Experimental studies on the neurogenic bladder. XIX. The morphological and pharmacological investigations on the canine posterior urethra (author's transl)]T Ohnuma
Chemical & Pharmaceutical Bulletin|October 1, 1993
Electrochemical oxidation of anti-tumor agent, etoposideR Obata, T Ohnuma
Selective Cancer Therapeutics|January 1, 1989
Effects of physiological oxygen environment on drug-induced cell lethality of multicellular tumor spheroids from human lung cancerS Inoue, T Ohnuma
The Mount Sinai Journal of Medicine, New York|October 1, 1992
N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexateY Takemura, T Ohnuma
Cancer Treatment Reports|January 1, 1981
Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B InvestigatorsJ F Holland, T Ohnuma
New York State Journal of Medicine|June 1, 1975
Plasmacytoma cell ascitesD J Higby, T Ohnuma
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1985
Homoharringtonine as a new antileukemic agentT Ohnuma, J F Holland
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Combination of chemotherapy and immunotherapy in man--review]T Ohnuma
Nippon Ganka Gakkai Zasshi|January 1, 1983
[Visual evoked potentials elicited by sinusoidal gratings in optic nerve disorders]T Ohnuma
Nippon Ganka Gakkai Zasshi|December 10, 1982
[Checkerboard pattern reversal VEPs in optic nerve disorders]T Ohnuma
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1979
[Experimental studies on the neurogenic bladder. XIX. The morphological and pharmacological investigations on the canine posterior urethra (author's transl)]T Ohnuma
Chemical & Pharmaceutical Bulletin|October 1, 1993
Electrochemical oxidation of anti-tumor agent, etoposideR Obata, T Ohnuma
Selective Cancer Therapeutics|January 1, 1989
Effects of physiological oxygen environment on drug-induced cell lethality of multicellular tumor spheroids from human lung cancerS Inoue, T Ohnuma
The Mount Sinai Journal of Medicine, New York|October 1, 1992
N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexateY Takemura, T Ohnuma
Cancer Treatment Reports|January 1, 1981
Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B InvestigatorsJ F Holland, T Ohnuma
New York State Journal of Medicine|June 1, 1975
Plasmacytoma cell ascitesD J Higby, T Ohnuma
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1985
Homoharringtonine as a new antileukemic agentT Ohnuma, J F Holland
Pageof 18